Search Login Register

bicalutamide (Casodex) Summary

Description: approved for treatment of advanced prostate cancer

Also Known As: Casodex; Cosudex; 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide; Astra brand of bicalutamide; AstraZeneca brand of bicalutamide Show All >>

Networked: 509 relevant articles (57 outcomes, 132 trials/studies) for this Drug

Key Diseases for which bicalutamide is Relevant

  1. Prostatic Neoplasms (Prostate Cancer) : 42 outcomes 105 studies in 400 results
  2. Neoplasms (Cancer) : 6 outcomes 11 studies in 62 results
  3. Pain (Aches) : 3 outcomes 7 studies in 30 results
  4. Gynecomastia : 3 outcomes 5 studies in 23 results
  5. Carcinoma (Carcinomatosis) : 3 outcomes 3 studies in 20 results
Show All >>

Drugs Related to bicalutamide

  1. Gonadotropin-Releasing Hormone (GnRH)
  2. Flutamide (Eulexin)
  3. Goserelin (Zoladex)
  4. Tamoxifen
  5. acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide
  6. bicalutamide (Casodex)
  7. nilutamide (Nilandron)
  8. BMS 641988
  9. Hormones
  10. Androgen Antagonists (Antiandrogens)
Show All >>

Therapies Related to bicalutamide

  1. Castration
  2. Radiotherapy
  3. Heterologous Transplantation (Xenotransplantation)
  4. Prostatectomy (Retropubic Prostatectomy)
  5. Brachytherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.